

Pune, India – August 28, 2018 —
The Global Asthma Inhaler Device Market has been observing continued growth and is expected to capture a CAGR of 5.2% over the forecast period of 2017–2023, reveals Market Research Future (MRFR), in a minutely analyzed research report.
The high incidence rate of respiratory disorders, particularly COPD and asthma spur the market growth.
LTD. (India), Merck & Co., Inc. (US), Aristopharma Ltd. (Bangladesh), and Intas Pharmaceuticals, Ltd. (India).
Asthma Inhaler Device Market – Updates
May 2018, a new asthma device which requires less force to activate has been created by engineers at the University of Cape Town.





